Posted by: admin | December 6, 2014

FDA to Revamp Approval Path for OTC Drugs

FDA to Revamp Approval Path for OTC Drugs
The agency said it is contemplating certain specific changes that it details in a Federal Register notice to be posted Friday. These include improving the FDA's ability to quickly require new warnings or label changes as safety issues emerge based on …
Read more on Wall Street Journal

Rhinomed Limited (ASX:RNO) Turbine Achieves CE Mark Registration
Having successfully registered the Turbine with the US FDA authority earlier this year, complying with the requirements necessary to gain a CE Mark was vital. Our team is focused on building our global sport business and this allows a much wider range …
Read more on ABN Newswire (press release)


Leave a Reply

Your email address will not be published. Required fields are marked *

Categories